Netanyahu and Trump at the White House. Photo: Olivier Douliery-Pool/Getty Images

The Trump administration is blocking a $500 million arms deal between Israel and Croatia, for the sale of 12 U.S.-made F-16 fighter jets refurbished and upgraded by Israel, Israeli officials tell me.

Why it matters: The U.S. was also fighting for the Croatia tender, and U.S. officials claimed Israel was being dishonest and trying to profit off the back of the U.S., according to the Israeli officials. This is a very rare standoff after two years of incredibly close relations between Israel and the Trump administration, especially when it comes to military and defense cooperation.

The latest: Israeli Prime Minister Benjamin Netanyahu raised the issue with Secretary of State Mike Pompeo during their meeting in Brussels on Monday, according to Israeli officials who said Pompeo told Netanyahu he was not against the deal but Secretary of Defense James Mattis was blocking it.

How things broke down ...

Netanyahu announced the deal last March after a meeting with his Croatian counterpart, but the U.S. didn't give Israel the approval needed to sell the jets to a third party. Israeli officials tell me they started receiving messages from Washington three weeks ago indicating that the U.S. would block the deal.

  • Trump administration officials were furious that Israel upgraded the old F-16's with new and sophisticated Israeli-made electronic systems in order persuade the Croatians to buy the jets from Israel and not from the U.S., the Israeli officials tell me.
  • The Americans claimed Israel was never supposed to sell the U.S.-made jets to a third party without U.S. approval — especially not in direct competition with the U.S.
  • Israeli officials tell me the Croatians are also furious that the deal is stuck and have conveyed a message to Israel that they expect it solve the problem as soon as possible. 

Netanyahu's office did not deny this account but refrained from commenting. The State Department declined to comment on the issue, and the Pentagon hasn't provided a comment.

Go deeper

Updated 41 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 7:30 p.m. ET: 13,258,016 — Total deaths: 576,752 — Total recoveries — 7,366,845Map.
  2. U.S.: Total confirmed cases as of 7:30 p.m. ET: 3,416,222 — Total deaths: 136,319 — Total recoveries: 1,049,098 — Total tested: 41,764,557Map.
  3. Politics: Biden welcomes Trump wearing mask in public but warns "it’s not enough"
  4. Public health: Four former CDC heads say Trump's undermining of agency puts lives at risk — CDC director: U.S. could get coronavirus "under control" in 4–8 weeks if all wear masks.

Bank CEOs brace for worsening economic scenario

JPMorgan CEO Jamie Dimon. Photo: J. Lawler Duggan/For The Washington Post via Getty Images

Wells Fargo swung to its first loss since the financial crisis — while JPMorgan Chase and Citigroup reported significantly lower profits from a year earlier — as the banks set aside billions of dollars more in the second quarter for loans that may go bad.

Why it matters: The cumulative $28 billion in loan loss provisions that banks have so far announced they’re reserving serves as a signal they’re preparing for a colossal wave of loan defaults as the economy slogs through a coronavirus-driven downturn.

3 hours ago - Health

Moderna's vaccine spurred immune system response to coronavirus

Moderna's stock rose 16% after hours on this news. Photo: Jakub Porzycki/NurPhoto via Getty Images

Healthy volunteers who took Moderna's coronavirus vaccine candidate appeared to generate an immune system response to the virus, and there were "no trial-limiting safety concerns," according to a new study published in the New England Journal of Medicine.

Why it matters: The phase one trial is still small and does not definitively determine how effective the vaccine is. But Anthony Fauci of the National Institutes of Health, which is running the trial, told the Wall Street Journal that these data make it "pretty clear that this vaccine is capable of inducing quite good [levels] of neutralizing antibodies."